Docosahexaenoic acid attenuates mycotoxin-induced immunoglobulin a nephropathy, interleukin-6 transcription, and mitogen-activated protein kinase phosphorylation in mice.
The purpose of this investigation was to evaluate the dose-dependent effects of docosahexaenoic acid (DHA) on deoxynivalenol (DON)-induced IgA nephropathy in mice and their relation to proinflammatory gene expression and mitogen-activated protein kinase (MAPK) activation. Consumption of a modified AIN-93G diet containing 1, 5, and 30 g/kg DHA resulted in dose-dependent increases of DHA in liver phospholipids with concomitant decreases in arachidonic acid compared with control diets. DHA dose dependently inhibited increases in serum IgA and IgA immune complexes (IC) as well as IgA deposition in the kidney in DON-fed mice; the 30 g/kg DHA diet had the earliest detectable effects and maximal efficacy. Both splenic interleukin-6 (IL-6) mRNA and heterogeneous nuclear RNA (hnRNA), an indicator of IL-6 transcription, were significantly reduced in DON-fed mice that consumed 5 and 30 g/kg DHA; a similar reduction was observed for cyclooxygenase (COX-2) mRNA. In a subsequent study, acute DON exposure (25 mg/kg body weight) induced splenic IL-6 mRNA and hnRNA as well as COX-2 mRNA in mice fed the control diet, whereas induction of both RNA species was significantly inhibited in mice fed 30 g/kg DHA. These latter inhibitory effects corresponded to a reduction in DON-induced phosphorylation of p38, extracellular-signal related kinase 1/2, and c-Jun N-terminal kinase 1/2 MAPKs in the spleen. Taken together, the results indicate that DHA dose-dependently inhibited DON-induced IgA dysregulation and nephropathy, and that impairment of MAPK activation and expression of COX-2 and IL-6 are potential critical upstream mechanisms.
Jia
Qunshan
Q
Department of Food Science and Human Nutrition, Michigan State University, East Lansing, MI 48823, USA.
Zhou
Hui-Ren
HR
Bennink
Maurice
M
Pestka
James J
JJ
D000818:Animals; D004281:Docosahexaenoic Acids / Q000494:pharmacology*; D005260:Female; D005922:Glomerulonephritis, IGA / Q000139:chemically induced / Q000517:prevention & control*; D015850:Interleukin-6 / Q000235:genetics*; D051379:Mice; D008815:Mice, Inbred Strains; D020928:Mitogen-Activated Protein Kinases / Q000187:drug effects / Q000378:metabolism; D009183:Mycotoxins / Q000633:toxicity*; D010766:Phosphorylation; D012332:RNA, Heterogeneous Nuclear / Q000235:genetics; D012333:RNA, Messenger / Q000187:drug effects / Q000235:genetics; D014255:Trichothecenes / Q000633:toxicity
D015850:Interleukin-6; D009183:Mycotoxins; D012332:RNA, Heterogeneous Nuclear; D012333:RNA, Messenger; D014255:Trichothecenes; D004281:Docosahexaenoic Acids; D020928:Mitogen-Activated Protein Kinases; C007262:deoxynivalenol